Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Mcneil AB

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Subsidiary

Established: 1914-01-01

Employees: 501

Market Cap: -

Website: http://www.mcneilab.se

Clinical Trials

Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine Patch
Drug: Placebo Patch
Drug: SLS Comparator Patch

First Posted Date: 2009-08-27

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 42

Registration Number: NCT00967174

Locations: 🇩🇪
IKP GmbH, Mannheim, Germany

Photoirritation and Photoallergic Potential of a New Nicotine Patch

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine Patch
Drug: Placebo Patch
Drug: No Patch Control
Radiation: UVA and UVB irradiation

First Posted Date: 2009-08-27

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 43

Registration Number: NCT00966901

Locations: 🇩🇪
IKP GmbH, Mannheim, Germany

Skin Sensitization Potential of a New Nicotine Patch

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine Patch
Drug: Placebo Patch

First Posted Date: 2009-08-27

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 257

Registration Number: NCT00967070

Locations: 🇩🇪
IKP GmbH, Mannheim, Germany

Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine Patch
Drug: Nicotine Patch Comparator
Drug: Placebo Patch

First Posted Date: 2009-08-26

Last Posted Date: 2012-06-29

Lead Sponsor: McNeil AB

Target Recruit Count: 42

Registration Number: NCT00965913

Locations: 🇩🇪
IKP, Mannheim, Germany

Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Drug: Placebo
Drug: Nicotine

First Posted Date: 2009-04-16

Last Posted Date: 2012-07-02

Lead Sponsor: McNeil AB

Target Recruit Count: 479

Registration Number: NCT00882375

Locations: 🇩🇰
Gentofte University Hospital, Hellerup, Denmark
🇩🇪
University of Heidelberg, Mannheim, Germany
🇩🇪
University Hospital of Tuebingen, Tuebingen, Germany

Smoking Reduction or Cessation With Nicotine Replacement Therapy

Phase 3

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine gum
Drug: Placebo gum
Drug: Nicotine inhaler
Drug: Placebo inhaler

First Posted Date: 2009-02-10

Last Posted Date: 2012-04-25

Lead Sponsor: McNeil AB

Target Recruit Count: 314

Registration Number: NCT00840242

Locations: 🇨🇿
Smoking Cessation Clinic, Kutna Hora, Czech Republic
🇨🇿
Institute of Hygiene and Epidemiology, Prague, Czech Republic

A Comparison of Three Medications to Treat Diarrhea in Adults.

Phase 4

Completed

Conditions: Diarrhea

Interventions: Drug: Loperamide/simeticone 2 mg/125 mg caplets
Drug: Loperamide/simeticone 2 mg/125 mg chewable tablets
Drug: Probiotic Saccharomyces boulardii 250 mg capsules

First Posted Date: 2008-12-11

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 415

Registration Number: NCT00807326

Locations: 🇮🇳
Manipal Goa Hospital, Goa, India
🇮🇳
Vrundavan Hospital & Research Centre, Goa, India
🇲🇽
North West Medical, San José del Cabo, Baja California Sur, Mexico

and more 3 locations

Pilot Study of a New Nicotine Replacement Therapy

Phase 2

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine replacement therapy

First Posted Date: 2008-10-02

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 258

Registration Number: NCT00764439

Locations: 🇬🇧
Department of Primary Care and General Practice, University of Birmingham, Birmingham, United Kingdom
🇬🇧
Tobacco Dependence Research Centre at Barts and The London Queen Mary's School of Medicine and Dentistry, London, United Kingdom

Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment

Phase 4

Completed

Conditions: Tobacco Dependence

Interventions: Drug: Nicotine Gum
Drug: Nicotine Patch

First Posted Date: 2008-09-09

Last Posted Date: 2012-07-13

Lead Sponsor: McNeil AB

Target Recruit Count: 300

Registration Number: NCT00749463

Locations: 🇨🇳
Beijing ChaoYang Hospital, Beijing, Beijing, China
🇨🇳
People's Hospital affiliated to Beijing University, Beijing, Beijing, China
🇨🇳
No. 1 Hospital affiliated to Zhongshan University, Guangzhou, Guangdong, China

and more 3 locations

Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold

Phase 4

Completed

Conditions: Common Cold
Headache
Nasal Congestion

Interventions: Drug: Pseudoephedrine/Paracetamol

First Posted Date: 2006-09-19

Last Posted Date: 2012-07-10

Lead Sponsor: McNeil AB

Target Recruit Count: 469

Registration Number: NCT00378144

Locations: 🇧🇪
JJCPPW Investigational Site, Wilrijk, Antwerp, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy